Showing results (51-60 of 103) with videos related to
Sort By:
Pageof 11
Pathology|November 27, 2007
Clinical and pathological features of eosinophilic oesophagitis: a reviewFuju Chang, Simon AndersonAlimentary Pharmacology & Therapeutics|July 5, 2021
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switchRaphael P Luber, Rhona O'Neill, Sukhpreet Singh, et al.Journal of Crohn'S & Colitis|April 14, 2020
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK ExperienceSailish Honap, Desmond Chee, Thomas P Chapman, et al.Echo Research and Practice|December 23, 2015
What's the risk? Assessment of patients with stable chest painArzu Cubukcu, Ian Murray, Simon AndersonDigestive Diseases and Sciences|January 27, 2025
Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International StudySailish Honap, Bénédicte Caron, Jacob E Ollech, et al.Micropublication Biology|May 25, 2026
Location and organization of a complex, integrated transgenic array in a Caenorhabditis elegans strain carrying hlh-29p::gfpSimon Anderson, Karen Barnard-Kubow, Casonya JohnsonCarcinogenesis|July 13, 2010
Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cellsChin Wee Ang, Taoufik Nedjadi, Adnan A Sheikh, et al.The Journal of ECT|December 20, 2007
Respiratory failure secondary to malignant catatonia and klinefelter pulmonary deficits: successful electroconvulsive therapyAdrian Barnardo, Omar Pathmanaban, Nagum Dawood, et al.Emergency Medicine Journal : EMJ|March 23, 2010
Spotting the complex tachycardiaAhmed Mahdi, Simon Anderson, Simon Carley, et al.Alimentary Pharmacology & Therapeutics|October 15, 2024
Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC ConsortiumParambir S Dulai, Lauren Balmert Bonner, Charlotte Sadler, et al.Pageof 11